0000000000122554

AUTHOR

María Mar López-rodríguez

showing 7 related works from this author

Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Mu…

2020

Multiple sclerosis (MS) is a neurodegenerative disease that causes anthropometric changes characterised by functional disability, increase in fat mass, and decrease in lean mass. All these variables are related to a greater cardiac risk. The polyphenol epigallocatechin gallate (EGCG) and an increase in ketone bodies in the blood have been shown to have beneficial effects on anthropometric and biochemical variables related to cardiovascular activity. The aim of this study was to analyse the impact of the intervention with EGCG and ketone bodies on cardiac risk in MS patients. A population of 51 MS patients were randomly assigned to a control group and an intervention group (daily dose of 800…

MalePilot ProjectsKetone Bodies030204 cardiovascular system & hematologyEpigallocatechin gallatemultiple sclerosisCatechinBody Mass Indexchemistry.chemical_compound0302 clinical medicineFunctional abilityeducation.field_of_studyNutrition and Dieteticsbiology3-Hydroxybutyric AcidAnthropometryfood and beveragesMiddle AgedPON1C-Reactive ProteinTreatment OutcomeCardiovascular DiseasesKetone bodiesFemalelcsh:Nutrition. Foods and food supplyAdultmedicine.medical_specialtycardiac riskepigallocatechin gallateWaistCardiotonic AgentsMultiple SclerosisPopulationlcsh:TX341-641Article03 medical and health sciencesInternal medicinemedicineHumanseducationSerum AlbuminAnalysis of VarianceWaist-Height Ratiobusiness.industryAryldialkylphosphataseParaoxonaseEndocrinologychemistryHeart Disease Risk FactorsDietary Supplementsketone bodiesLean body massbiology.proteinbusiness030217 neurology & neurosurgeryFood Science
researchProduct

Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive…

2019

Abstract Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease which is pathogenically based on the mitochondrial alteration of motor neurons, causing progressive neuron death. While ALS is characterized by enormous oxidative stress, the Mediterranean diet has been seen to have high antioxidant power. Therefore, the aim of this study is to determine how the Mediterranean diet can improve mitochondrial activity, establishing the specific nutrients and, in addition, observing the pathogenic mechanisms related to the disease that would achieve this improvement. To this end, a comprehensive review of the literature was performed using PubMed. KBs have been observed to ha…

0301 basic medicineamyotrophic lateral sclerosismitochondria ; mediterranean diet ; amyotrophic lateral sclerosis ; ketone bodiesMediterranean dietReviewslcsh:TX341-641ReviewDiseaseMitochondrionBioinformaticsmedicine.disease_causeNeuroprotection03 medical and health sciences0302 clinical medicineKetogenesisMedicineAmyotrophic lateral sclerosisbusiness.industryfood and beveragesmediterranean dietmedicine.diseasemitochondria030104 developmental biologyketone bodiesbusinessNeuron deathlcsh:Nutrition. Foods and food supply030217 neurology & neurosurgeryOxidative stressFood ScienceFood Science & Nutrition
researchProduct

The Relation between Eating Habits and Abdominal Fat, Anthropometry, PON1 and IL-6 Levels in Patients with Multiple Sclerosis

2020

Background: Multiple sclerosis (MS) is a chronic neurodegenerative disease of an inflammatory, demyelinating and autoimmune nature. Diets with a high caloric density could be especially relevant in terms of the pathogenesis related to an increase in adipose tissue that is metabolically active and releases mediators, which can induce systemic inflammation and an increased oxidation state. The aim of this study was to analyse the eating habits related to calorie intake and their impact on abdominal obesity associated with anthropometric variables, the activity of the oxidation marker paraoxonase 1 (PON1), and interleukin 6 (IL-6) levelsin MS patients. Methods: An analytical and quantitative o…

0301 basic medicineMaleWaistPopulationAbdominal FatAdipose tissuePhysiologyinterleukin 6lcsh:TX341-641multiple sclerosisArticle03 medical and health sciences0302 clinical medicinefeeding behaviourMedicineHumansBody Weights and MeasureseducationAbdominal obesityeducation.field_of_study030109 nutrition & dieteticsNutrition and Dieteticsanthropometrybiologybusiness.industryAryldialkylphosphataseInterleukin-6Paraoxonasepon1 human proteinFeeding BehaviorAnthropometryPON1DietNutrition AssessmentPON1 human proteinbiology.proteinFemaleDisease Susceptibilitymedicine.symptombusinessBody mass indexlcsh:Nutrition. Foods and food supply030217 neurology & neurosurgeryBiomarkersFood Science
researchProduct

Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study

2020

Vitamin B1, or thiamine, is one of the most relevant vitamins in obtaining energy for the nervous system. Thiamine deficiency or lack of activity causes neurological manifestations, especially symptoms of depression, intrinsic to multiple sclerosis (MS) and related to its pathogenesis. On this basis, the aim of this study was to determine the possible relationship between the nutritional habits of patients with MS and the presence of depression. Therefore, a cross-sectional and observational descriptive study was conducted. An analysis of dietary habits and vitamin B1 consumption in a Spanish population of 51 MS patients was performed by recording the frequency of food consumption. Results …

AdultMaleVitaminvitamin B1Food HandlingHealth BehaviorNutritional StatusPhysiologyPilot Projectslcsh:TX341-641Significant negative correlationmultiple sclerosisArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDietary CarbohydratesmedicineHumansThiamine030212 general & internal medicineEating habitsDepression (differential diagnoses)Nutrition and Dieteticsbusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseDietSpanish populationCross-Sectional StudieschemistryDietary SupplementsdepressionFast FoodsFemaleThiamineObservational studySnacksbusinesslcsh:Nutrition. Foods and food supply030217 neurology & neurosurgeryFood Science
researchProduct

The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients

2021

(1) Background: Multiple sclerosis (MS) is pathogenically characterized by high oxidative stress and symptomatically by progressive muscle loss and increased body fat associated with the presence of depression. Epigallocatechin gallate (EGCG) (particularly present in green tea) and ketone bodies (in particular beta-hydroxybutyrate (BHB)), whose main source is coconut oil, have shown emotional benefits and body fat loss. The aim of this study was to assess the impact of EGCG and coconut oil on cortisol activity related to fat loss and depression in MS patients. (2) Methods: The study involved 51 MS patients who were randomly divided into an intervention group or a control group. The interven…

medicine.medical_specialtyepigallocatechin gallatefood.ingredientScience030209 endocrinology & metabolismEpigallocatechin gallatePlacebomedicine.disease_causemultiple sclerosisGeneral Biochemistry Genetics and Molecular BiologyArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicinefoodInternal medicinefatMedicineEcology Evolution Behavior and SystematicsDepression (differential diagnoses)coconut oilbusiness.industryQCoconut oilAlbuminBeck Depression InventoryPaleontologyfood and beveragesEndocrinologychemistrySpace and Planetary SciencedepressionKetone bodiesbusiness030217 neurology & neurosurgeryOxidative stressLife
researchProduct

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

2020

Background: Due to the inflammatory nature of multiple sclerosis (MS), interleukin 6 (IL-6) is high in blood levels, and it also increases the levels of anxiety related to functional disability. Epigallocatechin gallate (EGCG) decreases IL-6, which could be enhanced by the anti-inflammatory effect of high ketone bodies after administering coconut oil (both of which are an anxiolytic). Therefore, the aim of this study was to assess the impact of coconut oil and EGCG on the levels of IL-6, anxiety and functional disability in patients with MS. Methods: A pilot study was conducted for four months with 51 MS patients who were randomly divided into an intervention group and a control group. The …

Male0301 basic medicineTime FactorsMediterranean dietEmotionsPilot ProjectsEpigallocatechin gallateDiet Mediterraneanmultiple sclerosisGastroenterologyCatechinBody Mass IndexDisability Evaluationchemistry.chemical_compound0302 clinical medicineProspective Studiescoconut oilNutrition and DieteticsCoconut oilfood and beveragesMiddle AgedMultiple Sclerosis Chronic ProgressiveanxietyTreatment OutcomeAnxietyFemalemedicine.symptomlcsh:Nutrition. Foods and food supplyepigallocatechin gallatemedicine.medical_specialtyfood.ingredientmedicine.drug_classlcsh:TX341-641PlaceboAnxiolyticArticle03 medical and health sciencesMultiple Sclerosis Relapsing-RemittingfoodInternal medicinemedicineHumansExpanded Disability Status Scalebusiness.industryinterleukin-6Recovery of Function030104 developmental biologydisabilitychemistrySpainDietary SupplementsbusinessBody mass indexBiomarkers030217 neurology & neurosurgeryFood ScienceNutrients
researchProduct

Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report.

2021

Background and objectives: The aim of this study was to report a case of a patient with Charcot-Marie-Tooth disease type 2 (CMT2) treated with epigallocatechin gallate (EGCG) for 4 months in order to assess its therapeutic potential in CMT2. Materials and Methods: The study included a brother and a sister who have CMT2. The sister received 800 mg of EGCG for 4 months, while her brother received placebo for the same period of time. Both participants were assessed before and after daily administration by means of anthropometry; analysis of inflammatory and oxidation markers of interleukin-6 (IL-6) and paraoxonase 1 (PON1) in the blood sample; and motor tests: 2-min walk test (2MWT), 10-m walk…

Malemedicine.medical_specialtyepigallocatechin gallateCase ReportWalk TestDiseaseEpigallocatechin gallatePlaceboCatechinchemistry.chemical_compoundTooth diseaseCharcot-Marie-Tooth DiseaseInternal medicineMedicineHumansCharcot-Marie-Tooth disease type 2lcsh:R5-920IL-6biologyHand Strengthbusiness.industrymotor activityAryldialkylphosphataseParaoxonaseparaoxonase 1General MedicineAnthropometryPON1chemistryWalk testbiology.proteinFemalebusinesslcsh:Medicine (General)
researchProduct